Skip to main content
Clinical Trials/JPRN-UMIN000019368
JPRN-UMIN000019368RecruitingPhase 2

Safety and efficacy of postoperative enoxaparin treatment in patients undergoing curative hepatobiliary-pancreatic cancer surgery: a prospective, Phase Two, multi-center study - Safety and efficacy of postoperative enoxaparin treatment in patients undergoing curative hepatobiliary-pancreatic cancer surgery: a prospective, Phase Two, multi-center study

Department of Surgery, Osaka University Graduate School of Medicine0 sites260 target enrollmentStarted: October 15, 2015Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
260

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Pancreatic Head Resection Major Hepatectomy with bile duct reconstruction

Investigators

Sponsor
Department of Surgery, Osaka University Graduate School of Medicine

Similar Trials